PSTX
Dimensional Fund Advisors’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-463,683
| Closed | -$4.45M | – | 3391 |
|
|
2024
Q4 | $4.45M | Sell |
463,683
-99,452
| -18% | -$954K | ﹤0.01% | 2567 |
|
|
2024
Q3 | $1.61M | Sell |
563,135
-36,677
| -6% | -$105K | ﹤0.01% | 2829 |
|
|
2024
Q2 | $1.75M | Buy |
599,812
+9,672
| +2% | +$28.2K | ﹤0.01% | 2795 |
|
|
2024
Q1 | $1.88M | Buy |
590,140
+102,939
| +21% | +$328K | ﹤0.01% | 2806 |
|
|
2023
Q4 | $1.64M | Buy |
487,201
+100,939
| +26% | +$339K | ﹤0.01% | 2826 |
|
|
2023
Q3 | $920K | Sell |
386,262
-314,264
| -45% | -$748K | ﹤0.01% | 2946 |
|
|
2023
Q2 | $1.23M | Sell |
700,526
-53,599
| -7% | -$94.3K | ﹤0.01% | 2890 |
|
|
2023
Q1 | $2.32M | Buy |
754,125
+477,706
| +173% | +$1.47M | ﹤0.01% | 2713 |
|
|
2022
Q4 | $1.47K | Buy |
276,419
+155,476
| +129% | +$824 | ﹤0.01% | 2809 |
|
|
2022
Q3 | $428K | Sell |
120,943
-24,089
| -17% | -$85.2K | ﹤0.01% | 3076 |
|
|
2022
Q2 | $374K | Buy |
145,032
+465
| +0.3% | +$1.2K | ﹤0.01% | 3131 |
|
|
2022
Q1 | $648K | Buy |
144,567
+47,233
| +49% | +$212K | ﹤0.01% | 3093 |
|
|
2021
Q4 | $663K | Buy |
+97,334
| New | +$663K | ﹤0.01% | 3111 |
|